The Anxiolytic Effect of the Neuropeptide Cycloprolylglycine Is Mediated by AMPA and TrkB Receptors
Previously we have shown that the neuropeptide cycloprolylglycine is an endogenous positive modulator of AMPA receptors and assumed that the pharmacological effects of CPG are associated with the brain neurotrophic factor. In this paper, we have first demonstrated that DNQX, an inhibitor of AMPA rec...
Gespeichert in:
| Veröffentlicht in: | Doklady. Biochemistry and biophysics 2020-07, Vol.493 (1), p.190-192 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 192 |
|---|---|
| container_issue | 1 |
| container_start_page | 190 |
| container_title | Doklady. Biochemistry and biophysics |
| container_volume | 493 |
| creator | Gudasheva, T. A. Povarnina, P. Yu Koliasnikova, K. N. Alyaeva, A. G. Vorontsova, O. N. Seredenin, S. B. |
| description | Previously we have shown that the neuropeptide cycloprolylglycine is an endogenous positive modulator of AMPA receptors and assumed that the pharmacological effects of CPG are associated with the brain neurotrophic factor. In this paper, we have first demonstrated that DNQX, an inhibitor of AMPA receptors, and K252A, an ihibitor of Trk receptors, prevented the anxiolytic effect of CPG, which confirms the formulated hypothesis. |
| doi_str_mv | 10.1134/S1607672920040067 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2440663867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2440676204</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-c8d753ee6dcf9e3487f7c2a967a164ab014ea77657721e8e08c3f100ee2a49e93</originalsourceid><addsrcrecordid>eNp1kctOwzAQRS0E4v0BbJAlNmwC40ftZFmqApUoICjryHUmkJImxU4k8ve4tIAEYuWR77l3RjOEHDE4Y0zI80emQCvNEw4gAZTeILvhK44EJGzzs9bRUt8he97PADhw0dsmO4LHiZSK7xI7eUHar96LuuyawtJhnqNtaJ3TJgi32Lp6gYumyJAOOlvWCxfA8rnsbFEhHXk6xqwwDWZ02tH--L5PTZXRiXu9oA9og7N2_oBs5ab0eLh-98nT5XAyuI5u7q5Gg_5NZKWIm8jGme4JRJXZPEEhY51ry02itGFKmikwiUZr1dOaM4wRYityBoDIjUwwEfvkdJUbhnxr0TfpvPAWy9JUWLc-5VKCUiJWOqAnv9BZ3boqTLeitOIgA8VWlHW19w7zdOGKuXFdyiBdXiD9c4HgOV4nt9M5Zt-Or5UHgK8AH6TqGd1P6_9TPwBxZo5y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2440676204</pqid></control><display><type>article</type><title>The Anxiolytic Effect of the Neuropeptide Cycloprolylglycine Is Mediated by AMPA and TrkB Receptors</title><source>MEDLINE</source><source>SpringerLink</source><creator>Gudasheva, T. A. ; Povarnina, P. Yu ; Koliasnikova, K. N. ; Alyaeva, A. G. ; Vorontsova, O. N. ; Seredenin, S. B.</creator><creatorcontrib>Gudasheva, T. A. ; Povarnina, P. Yu ; Koliasnikova, K. N. ; Alyaeva, A. G. ; Vorontsova, O. N. ; Seredenin, S. B.</creatorcontrib><description>Previously we have shown that the neuropeptide cycloprolylglycine is an endogenous positive modulator of AMPA receptors and assumed that the pharmacological effects of CPG are associated with the brain neurotrophic factor. In this paper, we have first demonstrated that DNQX, an inhibitor of AMPA receptors, and K252A, an ihibitor of Trk receptors, prevented the anxiolytic effect of CPG, which confirms the formulated hypothesis.</description><identifier>ISSN: 1607-6729</identifier><identifier>EISSN: 1608-3091</identifier><identifier>DOI: 10.1134/S1607672920040067</identifier><identifier>PMID: 32894462</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Animals ; Anti-Anxiety Agents - pharmacology ; Anxiety Disorders - drug therapy ; Anxiety Disorders - metabolism ; Anxiety Disorders - pathology ; Biochemistry ; Biological and Medical Physics ; Biomedical and Life Sciences ; Biophysics ; Brain-Derived Neurotrophic Factor - metabolism ; Carbazoles - pharmacology ; Enzyme Inhibitors - pharmacology ; Excitatory Amino Acid Antagonists - pharmacology ; Indole Alkaloids - pharmacology ; Life Sciences ; Male ; Membrane Glycoproteins - antagonists & inhibitors ; Mice ; Mice, Inbred BALB C ; Molecular Biology ; Neuropeptides ; Neurotrophic factors ; Peptides, Cyclic - chemistry ; Peptides, Cyclic - pharmacology ; Protein-Tyrosine Kinases - antagonists & inhibitors ; Quinoxalines - pharmacology ; Receptors, AMPA - antagonists & inhibitors ; Trk receptors ; TrkB receptors ; α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid ; α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors</subject><ispartof>Doklady. Biochemistry and biophysics, 2020-07, Vol.493 (1), p.190-192</ispartof><rights>Pleiades Publishing, Ltd. 2020</rights><rights>Pleiades Publishing, Ltd. 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-c8d753ee6dcf9e3487f7c2a967a164ab014ea77657721e8e08c3f100ee2a49e93</citedby><cites>FETCH-LOGICAL-c438t-c8d753ee6dcf9e3487f7c2a967a164ab014ea77657721e8e08c3f100ee2a49e93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1134/S1607672920040067$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1134/S1607672920040067$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32894462$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gudasheva, T. A.</creatorcontrib><creatorcontrib>Povarnina, P. Yu</creatorcontrib><creatorcontrib>Koliasnikova, K. N.</creatorcontrib><creatorcontrib>Alyaeva, A. G.</creatorcontrib><creatorcontrib>Vorontsova, O. N.</creatorcontrib><creatorcontrib>Seredenin, S. B.</creatorcontrib><title>The Anxiolytic Effect of the Neuropeptide Cycloprolylglycine Is Mediated by AMPA and TrkB Receptors</title><title>Doklady. Biochemistry and biophysics</title><addtitle>Dokl Biochem Biophys</addtitle><addtitle>Dokl Biochem Biophys</addtitle><description>Previously we have shown that the neuropeptide cycloprolylglycine is an endogenous positive modulator of AMPA receptors and assumed that the pharmacological effects of CPG are associated with the brain neurotrophic factor. In this paper, we have first demonstrated that DNQX, an inhibitor of AMPA receptors, and K252A, an ihibitor of Trk receptors, prevented the anxiolytic effect of CPG, which confirms the formulated hypothesis.</description><subject>Animals</subject><subject>Anti-Anxiety Agents - pharmacology</subject><subject>Anxiety Disorders - drug therapy</subject><subject>Anxiety Disorders - metabolism</subject><subject>Anxiety Disorders - pathology</subject><subject>Biochemistry</subject><subject>Biological and Medical Physics</subject><subject>Biomedical and Life Sciences</subject><subject>Biophysics</subject><subject>Brain-Derived Neurotrophic Factor - metabolism</subject><subject>Carbazoles - pharmacology</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Indole Alkaloids - pharmacology</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Membrane Glycoproteins - antagonists & inhibitors</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Molecular Biology</subject><subject>Neuropeptides</subject><subject>Neurotrophic factors</subject><subject>Peptides, Cyclic - chemistry</subject><subject>Peptides, Cyclic - pharmacology</subject><subject>Protein-Tyrosine Kinases - antagonists & inhibitors</subject><subject>Quinoxalines - pharmacology</subject><subject>Receptors, AMPA - antagonists & inhibitors</subject><subject>Trk receptors</subject><subject>TrkB receptors</subject><subject>α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid</subject><subject>α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors</subject><issn>1607-6729</issn><issn>1608-3091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctOwzAQRS0E4v0BbJAlNmwC40ftZFmqApUoICjryHUmkJImxU4k8ve4tIAEYuWR77l3RjOEHDE4Y0zI80emQCvNEw4gAZTeILvhK44EJGzzs9bRUt8he97PADhw0dsmO4LHiZSK7xI7eUHar96LuuyawtJhnqNtaJ3TJgi32Lp6gYumyJAOOlvWCxfA8rnsbFEhHXk6xqwwDWZ02tH--L5PTZXRiXu9oA9og7N2_oBs5ab0eLh-98nT5XAyuI5u7q5Gg_5NZKWIm8jGme4JRJXZPEEhY51ry02itGFKmikwiUZr1dOaM4wRYityBoDIjUwwEfvkdJUbhnxr0TfpvPAWy9JUWLc-5VKCUiJWOqAnv9BZ3boqTLeitOIgA8VWlHW19w7zdOGKuXFdyiBdXiD9c4HgOV4nt9M5Zt-Or5UHgK8AH6TqGd1P6_9TPwBxZo5y</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Gudasheva, T. A.</creator><creator>Povarnina, P. Yu</creator><creator>Koliasnikova, K. N.</creator><creator>Alyaeva, A. G.</creator><creator>Vorontsova, O. N.</creator><creator>Seredenin, S. B.</creator><general>Pleiades Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20200701</creationdate><title>The Anxiolytic Effect of the Neuropeptide Cycloprolylglycine Is Mediated by AMPA and TrkB Receptors</title><author>Gudasheva, T. A. ; Povarnina, P. Yu ; Koliasnikova, K. N. ; Alyaeva, A. G. ; Vorontsova, O. N. ; Seredenin, S. B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-c8d753ee6dcf9e3487f7c2a967a164ab014ea77657721e8e08c3f100ee2a49e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Anti-Anxiety Agents - pharmacology</topic><topic>Anxiety Disorders - drug therapy</topic><topic>Anxiety Disorders - metabolism</topic><topic>Anxiety Disorders - pathology</topic><topic>Biochemistry</topic><topic>Biological and Medical Physics</topic><topic>Biomedical and Life Sciences</topic><topic>Biophysics</topic><topic>Brain-Derived Neurotrophic Factor - metabolism</topic><topic>Carbazoles - pharmacology</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Indole Alkaloids - pharmacology</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Membrane Glycoproteins - antagonists & inhibitors</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Molecular Biology</topic><topic>Neuropeptides</topic><topic>Neurotrophic factors</topic><topic>Peptides, Cyclic - chemistry</topic><topic>Peptides, Cyclic - pharmacology</topic><topic>Protein-Tyrosine Kinases - antagonists & inhibitors</topic><topic>Quinoxalines - pharmacology</topic><topic>Receptors, AMPA - antagonists & inhibitors</topic><topic>Trk receptors</topic><topic>TrkB receptors</topic><topic>α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid</topic><topic>α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gudasheva, T. A.</creatorcontrib><creatorcontrib>Povarnina, P. Yu</creatorcontrib><creatorcontrib>Koliasnikova, K. N.</creatorcontrib><creatorcontrib>Alyaeva, A. G.</creatorcontrib><creatorcontrib>Vorontsova, O. N.</creatorcontrib><creatorcontrib>Seredenin, S. B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Doklady. Biochemistry and biophysics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gudasheva, T. A.</au><au>Povarnina, P. Yu</au><au>Koliasnikova, K. N.</au><au>Alyaeva, A. G.</au><au>Vorontsova, O. N.</au><au>Seredenin, S. B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Anxiolytic Effect of the Neuropeptide Cycloprolylglycine Is Mediated by AMPA and TrkB Receptors</atitle><jtitle>Doklady. Biochemistry and biophysics</jtitle><stitle>Dokl Biochem Biophys</stitle><addtitle>Dokl Biochem Biophys</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>493</volume><issue>1</issue><spage>190</spage><epage>192</epage><pages>190-192</pages><issn>1607-6729</issn><eissn>1608-3091</eissn><abstract>Previously we have shown that the neuropeptide cycloprolylglycine is an endogenous positive modulator of AMPA receptors and assumed that the pharmacological effects of CPG are associated with the brain neurotrophic factor. In this paper, we have first demonstrated that DNQX, an inhibitor of AMPA receptors, and K252A, an ihibitor of Trk receptors, prevented the anxiolytic effect of CPG, which confirms the formulated hypothesis.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><pmid>32894462</pmid><doi>10.1134/S1607672920040067</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1607-6729 |
| ispartof | Doklady. Biochemistry and biophysics, 2020-07, Vol.493 (1), p.190-192 |
| issn | 1607-6729 1608-3091 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2440663867 |
| source | MEDLINE; SpringerLink |
| subjects | Animals Anti-Anxiety Agents - pharmacology Anxiety Disorders - drug therapy Anxiety Disorders - metabolism Anxiety Disorders - pathology Biochemistry Biological and Medical Physics Biomedical and Life Sciences Biophysics Brain-Derived Neurotrophic Factor - metabolism Carbazoles - pharmacology Enzyme Inhibitors - pharmacology Excitatory Amino Acid Antagonists - pharmacology Indole Alkaloids - pharmacology Life Sciences Male Membrane Glycoproteins - antagonists & inhibitors Mice Mice, Inbred BALB C Molecular Biology Neuropeptides Neurotrophic factors Peptides, Cyclic - chemistry Peptides, Cyclic - pharmacology Protein-Tyrosine Kinases - antagonists & inhibitors Quinoxalines - pharmacology Receptors, AMPA - antagonists & inhibitors Trk receptors TrkB receptors α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors |
| title | The Anxiolytic Effect of the Neuropeptide Cycloprolylglycine Is Mediated by AMPA and TrkB Receptors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T18%3A10%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Anxiolytic%20Effect%20of%20the%20Neuropeptide%20Cycloprolylglycine%20Is%20Mediated%20by%20AMPA%20and%20TrkB%20Receptors&rft.jtitle=Doklady.%20Biochemistry%20and%20biophysics&rft.au=Gudasheva,%20T.%20A.&rft.date=2020-07-01&rft.volume=493&rft.issue=1&rft.spage=190&rft.epage=192&rft.pages=190-192&rft.issn=1607-6729&rft.eissn=1608-3091&rft_id=info:doi/10.1134/S1607672920040067&rft_dat=%3Cproquest_cross%3E2440676204%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2440676204&rft_id=info:pmid/32894462&rfr_iscdi=true |